A systematic study of P1–P3 spanning sidechains for the inhibition of HIV-1 protease-Reference-Cited by-同舟云学术

A systematic study of P1–P3 spanning sidechains for the inhibition of HIV-1 protease

Published:1995-04 Issue:7 Volume:5 Page:715-720
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Kaldor Stephen W.,Appelt Krzysztof,Fritz James E.,Hammond Marlys,Crowell Thomas A.,Baxter Angela J.,Hatch Steven D.,Wiskerchen MaryAnn,Muesing Mark A.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference11 articles.

1. HIV protease: a novel chemotherapeutic target for AIDS

2. Chapter 14. HIV Protease Inhibitors

3. Crystal structures of HIV-1 protease-inhibitor complexes

4. New dipeptide isosteres useful for the inhibition of HIV-1 protease

5. Abstracts of Papers, 208th National Meeting of the American Chemical Society;Kaldor,1994

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Merging lithium carbenoid homologation and enzymatic reduction: A combinative approach to the HIV-protease inhibitor Nelfinavir;Tetrahedron;2018-05

2. Advances in Non-peptidomimetic HIV Protease Inhibitors;Current Medicinal Chemistry;2014-04

3. First-Generation HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS;Aspartic Acid Proteases as Therapeutic Targets;2011-04-04

4. The FDA Approved HIV ‐1 Protease Inhibitors for Treatment of HIV / AIDS;Burger's Medicinal Chemistry and Drug Discovery;2010-08-27

5. Structure-Based Drug Design – The Use of Protein Structure in Drug Discovery;Comprehensive Medicinal Chemistry II;2007